Research provides the foundation for advances in medicine and for the development of innovative therapies. Bayer, as a research-based pharmaceutical company, focuses on the discovery and development of new treatment options for diseases with a high unmet medical need.
Bayer follows the strictest scientific and ethical principles, always in accordance with applicable law, when carrying out research on humans – especially when it comes to patient recruitment. Each patient needs to be aware of the possible benefits and risks involved in taking part in a clinical trial.
Clinical trials with medicinal products for pediatric use are certainly one of the most sensitive areas in science – both from a medical and an ethical standpoint. Everyone involved in clinical trials with children holds a special responsibility.
Non-interventional studies are usually conducted on the initiative of a pharmaceutical company. They may, however, also be required by a regulatory agency as a condition for product authorization or be obligatory, as in Korea or Japan.